Investment
Features
FeesSafety
Academy
More
Pluang+

Compare HSBC Holdings plc (HSBC) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance

HSBC Holdings plcTrade
Iovance Biotherapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

HSBC Holdings plc vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? HSBC Holdings plc trades at $92.84 (market cap $311.92B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.64 (market cap $6.04B). The key difference: HSBC Holdings plc is far larger — about 51.6× Iovance Biotherapeutics Inc. Common Stock's market cap, and HSBC Holdings plc pays a 4.05% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold HSBC Holdings plc for 36 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.

HSBCIOVA
Market Cap
$311.92B$6.04B
Volume
3,546,65814,805,993
Sector
FinancialsHealth
52-Week High
$107.86$14.82
52-Week Low
$65.67$1.81
Typical Hold Time
36 Days0 Days
Enterprise Value
$222.19B$5.97B
Dividend Yield
4.05%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

HSBC Holdings plc

HSBC trades at $92.80, down 0.97% with bearish technical signals. The stock shows strong profitability with 34.54% net margin and reasonable valuation at 13.23 P/E. Recent earnings were mixed with Q2 beat but Q1 miss. Analyst sentiment is cautious with 38% buy ratings. The bank is expanding in technology banking and US wealth services while restructuring European operations.

HSBC offers value with solid fundamentals but faces near-term headwinds from technical weakness and mixed earnings performance. Growth opportunities in Asian markets and wealth management balance risks from European restructuring and CFO transition in 2027.

Iovance Biotherapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HSBC
78% Buy22% Sell
Avg holding period · 36 Days
IOVA
100% Buy0% Sell
Avg holding period · 0 Days

About HSBC Holdings plc

HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.

Read more on HSBC →

About Iovance Biotherapeutics Inc. Common Stock

Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.

Read more on IOVA →